How to Buy Immunocore Holdings Stock
Immunocore Holdings PLC
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.
Immunocore Holdings stock last closed at $28.85, down 2.47% from the previous day, and has decreased 2.34% in one year. It has overperformed other stocks in the Biotechnology industry by 0.01 percentage points. Immunocore Holdings stock is currently +5.14% from its 52-week low of $27.44, and -29.14% from its 52-week high of $40.72.
At the moment, there are 50.87M shares of IMCR outstanding. The market cap of IMCR is $1.47B. In the last 24 hours, 158,000 IMCR shares were traded.
How to Buy Immunocore Holdings Stock
Wondering how to invest in Immunocore Holdings stock? Here's how.
- Figure out where to buy Immunocore Holdings stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you figure out where to buy Immunocore Holdings stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Select your payment method and add your information.
- Analyze Immunocore Holdings stock: The Immunocore Holdings ticker symbol is IMCR. Is Immunocore Holdings stock a good investment? Should you buy shares of IMCR? How do IMCR's underlying business fundamentals look? Do top analysts think Immunocore Holdings is a good buy? Why has IMCR's stock price moved recently? (Hint: Our stock market research website can help you decide if IMCR is a good stock to buy).
- Make your IMCR buy order: Decide if you will purchase IMCR shares at the current market price or use a limit order to buy IMCR shares at a specific price.
- Keep an eye on your IMCR investment: Create a watchlist to get the latest news on your investment in Immunocore Holdings shares.
Step 1: Figure out where to buy Immunocore Holdings stock
You need an online brokerage account to access the NASDAQ market and buy IMCR stock.
Our recommended brokerage: eToro
Based on our experience, eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Industrials, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal info so you can invest in IMCR today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to start your new brokerage account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have finished signing up on the stocks app, you need to deposit funds:
Check out the video below if you need help transferring money into your investment account.
Step 4: Analyze Immunocore Holdings stock
After you have identified the best place to buy Immunocore Holdings stock, it's absolutely critical to research their stock prior to buying, so you truly comprehend the risk as well as the opportunity.
Immunocore Holdings quick stats
IMCR Due Diligence Checks
WallStreetZen was created to help everyday investors perform more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on IMCR's stock page.
What is the fair value of IMCR stock?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge IMCR's true value.
Using relative valuations metrics:
- IMCR may be undervalued based on its P/B ratio of 3.73x, relative to Biotechnology industry P/B ratio of 4.97x
You can access more valuation analysis on IMCR's stock here.
Is IMCR a healthy company?
Signs that IMCR is financially healthy:
- There are more short-term assets than long-term liabilities on the IMCR balance sheet.
- IMCR has cash burn of 30745000. It has sufficient cash and short-term investments to cover this for at least one year.
- IMCR has $844.90M in cash and short term investments. This is sufficient to cover its annual cash burn of $30.75M.
- There are more short-term assets than short-term liabilities on the IMCR balance sheet.
Signs that IMCR is not financially healthy:
- IMCR has a relatively high debt to equity ratio of 1.72.
- IMCR profit margin has gone down from -6.5% to -6.7% in the past year.
- Total IMCR debt is higher than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy IMCR stock
Out of 4 Wall Street analysts who give recommendations on IMCR, the consensus analyst rating on IMCR is a Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Immunocore Holdings stock forecast page.
IMCR Momentum
IMCR Earnings
Last year, IMCR revenue was $412.81M. Over the past 5 year, IMCR's revenue has gone up by 61.43% per year. This was faster than the Biotechnology industry average of 24.53%.
Find out more about IMCR's earnings and revenue performance here.
Who is buying/selling IMCR?
In the past 12 months, insiders at IMCR have sold more shares than they have bought.
David M. Berman, HEAD OF RD of IMCR, was the latest IMCR insider to sell. They sold $192,967.75 worth of IMCR shares on Feb 18, 2026.
Research more about who owns IMCR stock here.
Does IMCR provide a stable income stream?
No, Immunocore Holdings doesn't provide an income stream by paying out dividends.
What do other investors have to say about IMCR?
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Make your IMCR buy order
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually fine. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a particular price, place a limit order.
Hit the Open button and your broker will execute the order.
If you require more help with investing in stocks on eToro, watch the how to video below:
Step 6: Keep an eye on your IMCR investment
Now that you own some IMCR shares, you'll want to keep up with your new company.
Put IMCR on a watchlist to see the latest developments about your IMCR stock.
IMCR Feed
How to Buy Stock in Immunocore Holdings
To summarize, here are the 6 steps for buying Immunocore Holdings stock:
- Figure out where to buy Immunocore Holdings stock
- Open a brokerage account
- Deposit funds into your investment account
- Analyze Immunocore Holdings stock
- Make your IMCR buy order
- Keep an eye on your IMCR investment
If you need a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to monitor your new investment in Immunocore Holdings, hit the button below to create your watchlist.
Other "How To" Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.